Combinatorially selected guanosine-quartet structureis a potent inhibitor of human immunodeficiency virus envelope-mediated cellfusion.

Jacqueline R. Wyatt(Ionis Pharmaceuticals (United States)), David J. Ecker(University of Colorado Denver), Thomas Klimkait(Department of Biomedicine Basel), Robert W. Buckheit(Ionis Pharmaceuticals (United States)), Elizabeth L. DeBaets(Ionis Pharmaceuticals (United States)), Joseph L. Roberson(Ionis Pharmaceuticals (United States)), Bernard Rayner(Ionis Pharmaceuticals (United States)), Peter W. Davis(Ionis Pharmaceuticals (United States)), J.‐L. IMBACH(Ionis Pharmaceuticals (United States)), Timothy A. Vickers(Ionis Pharmaceuticals (United States))
Proceedings of the National Academy of Sciences
February 15, 1994
Cited by 300


Related Papers